Clinical pharmacological aspects of growth hormone administration.
Laursen
Torben
T
Department of Pharmacology, The Bartholin Building, University of Aarhus, and Medical Department M (Endocrinology & Diabetes), Aarhus University Hospital, Kommunehospitalet, Aarhus 8000, Denmark. tl@farm.au.dk
D000328:Adult; D000818:Animals; D015415:Biomarkers; D001823:Body Composition / Q000187:drug effects; D050260:Carbohydrate Metabolism; D002352:Carrier Proteins / Q000097:blood; D002648:Child; D004333:Drug Administration Routes; D013006:Growth Hormone / Q000008:administration & dosage* / Q000172:deficiency / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D050356:Lipid Metabolism; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008137:Longitudinal Studies; D010599:Pharmacokinetics; D011986:Receptors, Somatotropin / Q000187:drug effects / Q000378:metabolism; D015398:Signal Transduction
D015415:Biomarkers; D002352:Carrier Proteins; D018972:Insulin-Like Growth Factor Binding Protein 3; D011986:Receptors, Somatotropin; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; C051815:somatotropin-binding protein